Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
+$168M |
| 2 |
Exxon Mobil
XOM
|
+$120M |
| 3 |
GE HealthCare
GEHC
|
+$103M |
| 4 |
Visa
V
|
+$96.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$92.1M |
Top Sells
| 1 |
Walmart
WMT
|
+$331M |
| 2 |
JPMorgan Chase
JPM
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$102M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$98.9M |
| 5 |
ConocoPhillips
COP
|
+$80.4M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.03% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Altimmune
ALT
$324M
| $2.39M | ﹤0.01% |
566,501
+388,636
| +219% | +$1.64M |
|
2702
Telefonica
TEF
$29.9B
| $2.39M | ﹤0.01% |
558,203
+278,858
| +100% | +$1.19M |
|
2703
NI Holdings
NODK
$275M
| $2.38M | ﹤0.01% |
182,929
+5,083
| +3% | +$66.1K |
|
2704
Middlefield Banc Corp
MBCN
$238M
| $2.37M | ﹤0.01% |
84,651
-15,169
| -15% | -$425K |
|
2705
Farmers & Merchants Bancorp
FMAO
$353M
| $2.36M | ﹤0.01% |
97,152
-1,950
| -2% | -$47.4K |
|
2706
Cognyte Software
CGNT
$603M
| $2.36M | ﹤0.01% |
696,357
+186,235
| +37% | +$631K |
|
2707
Takeda Pharmaceutical
TAK
$48.3B
| $2.36M | ﹤0.01% |
143,115
+616
| +0.4% | +$10.2K |
|
2708
Generation Bio
GBIO
$40.3M
| $2.34M | ﹤0.01% |
54,484
+9,238
| +20% | +$397K |
|
2709
Enact Holdings
ACT
$5.71B
| $2.34M | ﹤0.01% |
102,386
+4,902
| +5% | +$112K |
|
2710
Xenon Pharmaceuticals
XENE
$2.86B
| $2.34M | ﹤0.01% |
65,266
-249,407
| -79% | -$8.93M |
|
|
BRT
2711
BRT Apartments
BRT
$290M
| $2.33M | ﹤0.01% |
118,149
+5,890
| +5% | +$116K |
|
|
LL
2712
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.32M | ﹤0.01% |
611,669
-157,679
| -20% | -$599K |
|
|
PSTX
2713
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.32M | ﹤0.01% |
754,125
+477,706
| +173% | +$1.47M |
|
2714
Purple Innovation
PRPL
$116M
| $2.32M | ﹤0.01% |
879,099
+568,618
| +183% | +$1.5M |
|
|
GHL
2715
DELISTED
Greenhill & Co., Inc.
GHL
| $2.3M | ﹤0.01% |
259,245
+40,072
| +18% | +$355K |
|
2716
Lantronix
LTRX
$184M
| $2.3M | ﹤0.01% |
528,958
+62,582
| +13% | +$272K |
|
|
USX
2717
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $2.27M | ﹤0.01% |
382,300
-129,112
| -25% | -$767K |
|
2718
Reading International Class A
RDI
$35M
| $2.26M | ﹤0.01% |
695,633
-16,126
| -2% | -$52.4K |
|
2719
Security National Financial
SNFCA
$231M
| $2.26M | ﹤0.01% |
420,559
+23,516
| +6% | +$126K |
|
2720
AMREP Corp
AXR
$116M
| $2.25M | ﹤0.01% |
160,974
-3,348
| -2% | -$46.8K |
|
2721
Rhythm Pharmaceuticals
RYTM
$6.66B
| $2.22M | ﹤0.01% |
124,509
-12,482
| -9% | -$223K |
|
2722
Plumas Bancorp
PLBC
$313M
| $2.2M | ﹤0.01% |
64,575
+3,860
| +6% | +$131K |
|
|
FSP
2723
Franklin Street Properties
FSP
$172M
| $2.19M | ﹤0.01% |
1,397,936
+4,305
| +0.3% | +$6.76K |
|
|
NOA
2724
North American Construction
NOA
$400M
| $2.19M | ﹤0.01% |
131,207
+4,408
| +3% | +$73.6K |
|
2725
MeiraGTx Holdings
MGTX
$603M
| $2.19M | ﹤0.01% |
423,370
+100,648
| +31% | +$520K |
|